tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Weed'

Nuvilex’s Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box

Nuvilex’s Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box

Written by ι Stock Market Media Group — February 12, 2014

Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that’s focused on getting into late phase clinical trials for the treatment of advanced, inoperable pancreatic cancer, but it also expects to be a major player in the medical marijuana arena.  And, to that end, last December, Nuvilex landed a leading figure in the medical marijuana field in Dr. Mark L. Rabe.  Dr. Rabe was appointed as the Chairman of the Scientific Advisory Board ...

Read More →
0

Marijuana Entrepreneur Jamen Shively Discusses Plandai Biotechnology, Branding Cannabis, and Legalization

Marijuana Entrepreneur Jamen Shively Discusses Plandai Biotechnology, Branding Cannabis, and Legalization

Written by ι Stock Market Media Group Staff — February 4, 2014

Plandaí Biotechnology (OTCQB: PLPL) recently entered into what could very well be the industry’s biggest agreement to date.  At the time, many investors may have viewed it as just another licensing agreement, but as Plandaí lays the groundwork for its future, the deal with Diego Pellicer, Inc. and Diego Pellicer Worldwide permits the company to use the Diego Pellicer name for its Phytofare™ cannabis extracts.  But, at the same time, it ...

Read More →
0

Plandai Biotechnology’s Medical Marijuana Subsidiary Will Introduce Marijuana Industry to Unzipping Molecules

Plandai Biotechnology’s Medical Marijuana Subsidiary Will Introduce Marijuana Industry to Unzipping Molecules

Written by ι Stock Market Media Group Staff — January 15, 2014

Plandaí Biotechnology, Inc. (OTCQB: PLPL) could hold the key to making what is a miracle drug for some, into an even more powerful miracle drug for many.  The company entered the medical marijuana industry with its wholly-owned subsidiary, Cannabis Biosciences, Inc., for the purpose of developing and testing a new Phytofare™ botanical extract derived from cannabis.  Researchers may quickly find that Plandaí’s “hydrodynamic sheering” process could deliver an extract that ...

Read More →
0

New Study Continues to Validate Nuvilex’s Approach to Medical Marijuana Research

New Study Continues to Validate Nuvilex’s Approach to Medical Marijuana Research

Written by ι Stock Market Media Group Staff — October 22, 2013

Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary, Medical Marijuana Sciences, Inc., received another validation of their efforts to bring research utilizing cannabidiol (CBD) as the basis for developing treatments for some of the deadliest forms of cancer to the industry.  This latest study serves as another piece of evidence in a mounting argument that cannabinoids from Cannabis, such as CBD, are effective anti-cancer drugs.   

It was a team at St ...

Read More →
0

Medical Marijuana Stocks and Legalization Movement Get Support from CNN’s Dr. Sanjay Gupta

Medical Marijuana Stocks and Legalization Movement Get Support from CNN’s Dr. Sanjay Gupta

NEW YORK, NY– (Aug 9, 2013) – Everyone is entitled to change their mind, and even doctors who hold strong opinions are allowed a mulligan every now and then.  CNN’s chief medical correspondent Dr. Sanjay Gupta is taking his “do-over” public in a new documentary titled Weed.  Gupta has just reversed his position on medical marijuana, and in doing so, he gives companies engaged in medical marijuana research like Nuvilex, Inc. (OTCQB: NVLX) and pro-cannabis groups in states all over the ...

Read More →
0
ContactUs.com